First Batch Of Anti-COVID Drug 2-DG Released

The Drugs Controller General of India (DGCI) approved the 2-deoxy D-glucose (2-DG) drug for emergency use as an adjunct therapy in moderate to severe coronavirus patients earlier this month.

The first batch of anti-COVID oral drug 2-DG, developed by the DRDO, was released on Monday by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan. The Drugs Controller General of India (DGCI) approved the 2-deoxy D-glucose (2-DG) drug for emergency use as an adjunct therapy in moderate to severe coronavirus patients earlier this month. In his brief remarks, Mr Singh said the drug has brought a new ray of hope for the treatment of COVID-19 patients. "This is a great example of the scientific prowess of our country," he said.